Learn how SOPHiA GENETICS can support you in overcoming the limitations and maximizing the ability to detect Homologous Recombination Repair (HRR) deficiency in somatic samples.

Following an introduction on the growing importance of broadening HRR deficiency detection beyond BRCA by Mikhail Pertziger, our Oncology Product Manager, Christian Pozzorini, our Director of Biostatistics Research, will present how our SOPHiA DDM™ Homologous Recombination Solutions evolved to include CNV screening in its variant detection capabilities.

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.